MIRM Q2 2021 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M

Gross Profit

$11M100.0% margin

Operating Income

-$37M-340.0% margin

Net Income

-$44M-399.0% margin

EPS (Diluted)

$-1.45

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$248M

Total Liabilities

$152M

Stockholders' Equity

$96M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$0	—
Gross Profit	$11M	$0	—
Operating Income	-$37M	-$24M	-58.5%
Net Income	-$44M	-$23M	-88.8%